Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Bleomycin Alone vs Combination with Dexamethasone in Infantile Haemangiomas
NCT06080724Completed
- Sponsor
- King Edward Medical University
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dexamethasone in infantile hemangioma (IH) (2 arms), sponsored by King Edward Medical University. Primary endpoint: Decrease in size of lesion at 1 year. Started Mar 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT06080724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06080724.